These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12124166)

  • 1. EGF receptor activation by heterologous mechanisms.
    Carraway KL; Sweeney C
    Cancer Cell; 2002 Jun; 1(5):405-6. PubMed ID: 12124166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
    Guerrero J; Santibañez JF; González A; Martínez J
    Exp Cell Res; 2004 Jan; 292(1):201-8. PubMed ID: 14720519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE; Saunders DN; Ranson M
    Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential signal transduction of epidermal-growth-factor receptors in hormone-dependent and hormone-independent human breast cancer cells.
    Mueller H; Loop P; Liu R; Wosikowski K; Kueng W; Eppenberger U
    Eur J Biochem; 1994 Apr; 221(2):631-7. PubMed ID: 8174543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ; Quinn JA; Frackelton AR; Bland KI
    Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of specific cell-surface binding of tissue plasminogen activator in uterine cells.
    Ayub M; Jenkins N; White JO
    J Mol Endocrinol; 1990 Aug; 5(1):7-14. PubMed ID: 2168711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
    Albo D; Rothman VL; Roberts DD; Tuszynski GP
    Br J Cancer; 2000 Aug; 83(3):298-306. PubMed ID: 10917542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
    Yue J; Sun B; Liu G; Mulder KM
    J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
    Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
    Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shh/Ptch and EGF/ErbB cooperatively regulate branching morphogenesis of fetal mouse submandibular glands.
    Mizukoshi K; Koyama N; Hayashi T; Zheng L; Matsuura S; Kashimata M
    Dev Biol; 2016 Apr; 412(2):278-87. PubMed ID: 26930157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.
    Foekens JA; Portengen H; Janssen M; Klijn JG
    Cancer; 1989 Jun; 63(11):2139-47. PubMed ID: 2541884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells.
    Egeblad M; Jäättelä M
    Int J Cancer; 2000 Jun; 86(5):617-25. PubMed ID: 10797281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers.
    Jankun J; Merrick HW; Goldblatt PJ
    J Cell Biochem; 1993 Oct; 53(2):135-44. PubMed ID: 8227186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma.
    Liu D; Aguirre Ghiso J; Estrada Y; Ossowski L
    Cancer Cell; 2002 Jun; 1(5):445-57. PubMed ID: 12124174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.
    Serratì S; Margheri F; Fibbi G; Di Cara G; Minafra L; Pucci-Minafra I; Liotta F; Annunziato F; Pucci M; Del Rosso M
    J Pathol; 2008 Apr; 214(5):545-54. PubMed ID: 18189329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer.
    Duggan C; Maguire T; McDermott E; O'Higgins N; Fennelly JJ; Duffy MJ
    Int J Cancer; 1995 May; 61(5):597-600. PubMed ID: 7768629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
    Kommoss F; Colley M; Hart CE; Franklin WA
    Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway.
    Marques SA; Dy LC; Southall MD; Yi Q; Smietana E; Kapur R; Marques M; Travers JB; Spandau DF
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1026-35. PubMed ID: 11861812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EGF receptor as central transducer of heterologous signalling systems.
    Zwick E; Hackel PO; Prenzel N; Ullrich A
    Trends Pharmacol Sci; 1999 Oct; 20(10):408-12. PubMed ID: 10577253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.